Nigeria Gets Twice-Yearly HIV Prevention Drug by March

Imagine getting protection from HIV with just two shots a year instead of daily pills. That's about to become reality for Nigerians starting this March.

The National Agency for the Control of AIDS announced that Nigeria will receive its first shipment of Lenacapavir, a revolutionary injectable drug that prevents HIV infection for six months at a time. This marks a major leap forward in making HIV prevention easier and more practical for people at high risk.

The twice-yearly injection offers a game-changing alternative to current prevention methods that require daily pills. For many people, remembering to take medication every single day can be challenging, but two doctor visits a year is far more manageable.

Nigeria isn't rushing into this rollout. The government has spent months preparing healthcare systems, training medical staff, and building community awareness in 10 priority states including Lagos, Kano, and the Federal Capital Territory.

Health officials have already completed readiness assessments across states like Akwa Ibom, Benue, Cross River, and Gombe. They've also created educational materials to help communities understand how the new prevention option works and who should consider it.

The Ripple Effect

This rollout could transform HIV prevention across Africa's most populous nation. When prevention becomes easier, more people use it, which means fewer new infections and healthier communities overall.

The phased introduction allows healthcare workers to learn best practices in initial states before expanding nationwide. This careful approach helps ensure everyone who needs the drug can access it with proper medical guidance and support.

Nigeria joins a growing number of countries embracing long-acting HIV prevention tools. The move signals strong commitment to epidemic control and puts cutting-edge medical innovation within reach of communities that need it most.

By March 2026, the first Nigerians will have access to a prevention method that fits seamlessly into their lives, requiring just two clinic visits annually instead of 365 pills. That's the kind of practical progress that saves lives.